Roivant Sciences (ROIV) Return on Sales Growth (1y) (2021 - 2025)
Roivant Sciences (ROIV) Return on Sales Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 0.00 |
| 10 | Roivant Sciences | 24.09 Bn | 24.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 22.00 |
| Jun 30, 2025 | -2.00 |
| Dec 31, 2024 | 27.00 |
| Sep 30, 2024 | 14.00 |
| Jun 30, 2024 | 26.00 |
| Dec 31, 2023 | 22.00 |
| Sep 30, 2023 | 2.00 |
| Jun 30, 2023 | 67.00 |
| Dec 31, 2022 | -17.00 |
| Sep 30, 2022 | -9.00 |
| Jun 30, 2022 | -69.00 |
| Dec 31, 2021 | 34.00 |
| Sep 30, 2021 | 24.00 |
| Jun 30, 2021 | -8.00 |